检索

期
标题
作者
卷 24, 编号 4 (2022)
Efficacy of immunotherapy (Prolgolimab) and targeted therapy (Trametinib and Dabrafenib, Cobimetinib and Vemurafenib) in adult patients with metastatic or unresectable skin melanoma: matching-adjusted indirect comparison
Sapozhnikov K., Sokolova V., Sableva N., Tolkacheva D.
PDF
(Rus)
卷 26, 编号 2 (2024)
Second line chemotherapy for advanced biliary cancer: FOLFOX versus FOLFIRI: Analysis of retrospective and prospective data
Savchenko I., Stilidi I., Dzhanyan I., Antonova E., Polyakov A., Egorova A., Chulkova S., Breder V.
PDF
(Rus)
卷 25, 编号 2 (2023)
Clinical significance of the pathological type of tumor in common forms of ovarian cancer: A retrospective study
Zhurman V.
PDF
(Rus)
卷 24, 编号 1 (2022)
Vascular endothelial growth factor (VEGF) targeting therapy for persistent, recurrent, or metastatic cervical cancer (Russian Translation of Cochrane Plain Language Summary)
Staroverova T.
PDF
(Rus)
卷 26, 编号 2 (2024)
Is maintenance therapy following previous treatment better than observation or placebo for treating chronic lymphocytic leukaemia in adults? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
PDF
(Rus)
卷 25, 编号 4 (2023)
Results of pelvic exenteration in patients with cervical cancer: clinical experience
Khakimov G., Khakimova G.
PDF
(Rus)
卷 26, 编号 2 (2024)
Do cancer vaccines help people with advanced non-small cell lung cancer? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review)
Editorial B.
PDF
(Rus)
卷 24, 编号 2 (2022)
Sarcopenia, sarcopenic obesity, myosteatosis as factors of poor prognosis in gastrointestinal tract tumors: sistematic review
Lyadov V., Dikova T., Zatsepina A., Ivashchenko D.
PDF
(Rus)
卷 24, 编号 2 (2022)
Current treatment aspects of hormone-dependent ERBB2-negative metastatic breast cancer: overall survival outcomes
Snegovoy A., Kononenko I.
PDF
(Rus)
卷 25, 编号 1 (2023)
Effect of transfused donor and autoerythrocytes on the oncological outcomes of surgical treatment in patients with renal cell carcinoma with tumor-related venous thrombosis: observational study
Volkova M., Feoktistov P., Begaliev A., Shin A., Matveev V., Prikhodchenko A.
PDF
(Rus)
卷 25, 编号 1 (2023)
Effective prevention of COVID-19 infection in cancer patients receiving antitumor drug therapy: a regional analysis
Valiachmetova C., Siraev E., Izmailov A.
PDF
(Rus)
卷 23, 编号 4 (2021)
Comparative analysis results of surgical treatment, chemoradiotherapy and chemotherapy with assessment of prognostic factors in cervical esophageal cancer
Radzhabova Z., Kotov M., Girshovich M., Ponomareva O., Tkachenko E., Mitrofanov A., Radzhabova M., Levchenko E.
PDF
(Rus)
卷 25, 编号 1 (2023)
The role of minimal residual disease in therapy of pediatric acute lymphoblastic leukemia: a prospective cohort study
Korkina Y., Valiev T.
PDF
(Rus)
卷 24, 编号 1 (2022)
Quality of life and overall survival are primary priorities of patients with advanced breast cancer: results of sociological research
Kolomejtseva A., Bokova S.
PDF
(Rus)
卷 18, 编号 3 (2016)
Therapy results of advanced-stag Hodgkin lymphoma in Khabarovsk district
Kanin V., Kanin E., Dolgaleva M.
PDF
(Rus)
卷 22, 编号 3 (2020)
Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
Popova A., Fedyanin M., Pokataev I., Tyulyandin S.
PDF
(Rus)
卷 24, 编号 4 (2022)
Fosaprepitant: current options to prevent chemotherapy-induced nausea and vomiting: A review
Ognerubov N.
PDF
(Rus)
卷 16, 编号 3 (2014)
Targeted therapy for metastatic renal cell carcinoma
Porta C., Tsimafeyev I.
卷 23, 编号 1 (2021)
Systemic treatments for metastatic cutaneous melanoma (Russian Translation of Cochrane Plain Language Summary – PLS)
Ziganshin A.
PDF
(Rus)
卷 19, 编号 2 (2017)
Clinico-morphological predictors and treatment outcomes in cervical stump cancer
Usmanova L., Kuznetsov V., Mustafina E., Barinov V., Bokin I., Knyazev R., Akhmedova M.
PDF
(Rus)
卷 23, 编号 1 (2021)
Second-line systemic therapy for metastatic colorectal cancer (Russian Translation of Cochrane Plain Language Summary – PLS)
Zaleeva A.
PDF
(Rus)
卷 18, 编号 2 (2016)
Development of cytotoxic chemotherapy in metastatic breast cancer with a triple-negative phenotype
Karabina E., Zhukova L.
PDF
(Rus)
卷 23, 编号 3 (2021)
Comparison of afatinib and osimertinib effect on overall survival in first-line drug treatment of EGFR-positive metastatic non-small cell lung cancer: network meta-analysis
Goryaynov S.
PDF
(Rus)
卷 20, 编号 3 (2018)
Vliyanie na prognoz estrogenovykh retseptorov a v opukholevykh kletkakh u patsientov, radikal'no operirovannykh po povodu nemelkokletochnogo raka legkogo
Novikov D., Polotskiy B., Bogush T., Davidov M., Ahmedov B., Rotobelskaya L.
PDF
(Rus)
卷 18, 编号 2 (2016)
New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
Semiglazova T., Klyuge V., Semiglazov V., Teletaeva G., Krivorotko P., Dashyan G., Paltuev R., Tkachenko E., Donskikh R., Semiglazov V.
PDF
(Rus)
卷 23, 编号 1 (2021)
Comparison of the efficacy of first-line therapy with different generations of EGFR tyrosine kinase inhibitors in patients with advanced EGFR-associated non-small cell lung cancer: a network meta-analysis of overall survival data
Bogdanov A., Moiseenko F., Egorenkov V., Bogdanov A., Volkov N., Fedyanin M.
PDF
(Rus)
卷 20, 编号 3 (2018)
Diagnosis and treatment of metastatic melanoma of unknown primary
Krylovetskaya M., Komarov I., Karseladze D.
PDF
(Rus)
卷 18, 编号 1 (2016)
Insulin-like growth factors in patients with ovarian tumors (results of own research)
Knyazev R., Kuznetsov V., Bokin I., Barinov V., Kushlinskiy N., Poddubnaya I.
PDF
(Rus)
卷 23, 编号 1 (2021)
Treatment of advanced small cell lung cancer. Clinical case and literature review
Menshikov K., Sultanbaev A., Musin S., Menshikova I., Nasretdinov A., Sultanbaeva N.
PDF
(Rus)
卷 20, 编号 3 (2018)
The role of capecitabine and eribulin in the treatment of metastatic HER2-negative metastatic breast cancer
Kolyadina I., Poddubnaya I.
PDF
(Rus)
卷 23, 编号 1 (2021)
Prognostic role of clinical and biological factors and parameters of hormonal profile in patients with primary inoperable HER2-negative breast cancer
Samaneva N., Vladimirova L., Kolyadina I., Frantsiyants E., Storozhakova A., Bandovkina V., Kalabanova E., Kabanov S., Svetitskaya I., Tishina A., Ezhova M.
PDF
(Rus)
卷 20, 编号 1 (2018)
Clinical significance of the achievement of MRD-negativity in patients with chronic lymphocytic leukemia
Mirolyubova Y., Stadnik E.
PDF
(Rus)
卷 15, 编号 2 (2013)
Prognostic value of p53 expression in patients with stage I breast cancer
Kolyadina I., Poddubnaya I., Van de Velde C., Kuppen P., Liefers G., Dekker-Ensink N., Bastiaannet E., Van As-Sajet A., Prinse B., Engels C., Van Vlierberghe R., Komov D., Karseladze A., Ermilova V., Vishnevskaya Y., Frank G., Banov S.
卷 23, 编号 1 (2021)
Don’t let it disappear: new opportunities to prolong the life of HR+ HER2- advanced breast cancer patients. Event review of the satellite symposium. RUSSCO Big Conference «Breast Cancer» (online). January 28th, 2021
Board E.
PDF
(Rus)
卷 19, 编号 4 (2017)
Head and neck cutaneous melanoma: an influence of surgical resection margin on long-term results
Pak M., Mudunov A., Demidov L., Azizyan R., Brzhezovskiy V., Stelmah D., Alymov Y., Ignatova A.
PDF
(Rus)
1 - 35 的 35 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##